Skip to content
Monday, Jun 1, 2026 BTC ETH Cap
English Deutsch soon Bahasa Indonesia soon 한국어 soon Português (BR) soon Türkçe soon
Live

Thermo Fisher Scientific Inc TMO

NYSE Healthcare Market closed
$492.51
▲ 5.29 (+1.09%)
Price Chart

Thermo Fisher Scientific Inc Stock Price Chart

$492.51 ▲ +1.09% TMO · NYSE
Key Statistics

Thermo Fisher Scientific Inc Key Statistics

Market Cap$183.03B
Price$492.51
Day High$499.00
Day Low$481.69
P/E Ratio27.11
Forward P/E18.04
EPS (TTM)$18.17
Dividend Yield0.38%
52-Week High$643.99
52-Week Low$385.46
Avg Volume2.26M
Beta0.88
Fundamentals

Fundamentals snapshot

Revenue (TTM)$45.20B
Net Income (TTM)$6.85B
Profit Margin15.2%
Gross Margin40.9%
Revenue Growth+6.20%
Shares Out.371.62M
Analyst Ratings

Wall Street analyst ratings

Consensus Strong Buy 25 analysts
SellHoldBuy
Low$490.00
Avg target$611.56+24.17%
High$750.00
Next earningsApr 23, 2026Quarterly report
Dividend yield0.38%$1.88/yr · ex-date Jun 15, 2026
Employees125,000United States
About Thermo Fisher Scientific Inc

About Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in

This page tracks Thermo Fisher Scientific Inc's live share price, valuation multiples and the latest news. For how we source and present market data, see our methodology.

News & FAQ

Latest Thermo Fisher Scientific Inc news

We're expanding our Thermo Fisher Scientific Inc coverage. In the meantime, browse the latest stock market news and live markets.

Other Healthcare stocks

Thermo Fisher Scientific Inc (TMO) FAQ

What is Thermo Fisher Scientific Inc (TMO)?

Thermo Fisher Scientific Inc is a publicly traded company listed on NYSE under the ticker TMO. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in

What is the TMO stock price today?

Thermo Fisher Scientific Inc (TMO) is trading at $492.51, up 1.09% on the day. Prices on this page update through the trading session. This is not financial advice.

Is TMO a buy?

Wall Street analysts currently rate TMO a consensus "Strong Buy", with an average 12-month price target of $611.56 (+24.17% vs the current price). Ratings are opinions, not guarantees — always do your own research.

When does Thermo Fisher Scientific Inc report earnings?

The next Thermo Fisher Scientific Inc earnings date is around Apr 23, 2026. Earnings dates can move — check the company's investor relations page to confirm.

Does TMO pay a dividend?

Thermo Fisher Scientific Inc pays a dividend with a current yield of about 0.38% ($1.88 per share annually).

Market data is provided for information only and may be delayed. Nothing on this page is investment advice or a recommendation to buy or sell TMO. Markets are volatile and investing carries risk — always do your own research.